Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

WAYNE BEAUFORD

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1043232606
CMS profile
137597
Location
HIGH POINT, NC

General Payments · PY2018–2024

$2,287.08

  • Reported across 124 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$371.15

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $371.15 16

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $78.92 6
PY2019 $286.24 27
PY2020 $247.23 17
PY2021 $696.27 32
PY2022 $355.83 11
PY2023 $251.44 15
PY2024 $371.15 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $22.47 01/29/2024 Food and Beverage Undisputed 01/23/2026 1103296342 CMS
AstraZeneca Pharmaceuticals LP $14.38 04/30/2024 Food and Beverage Undisputed 01/23/2026 1105682241 CMS
Boston Scientific Corporation $52.83 02/06/2024 Food and Beverage Undisputed 01/23/2026 1092355697 CMS
GENZYME CORPORATION $36.86 06/25/2024 Food and Beverage Undisputed 01/23/2026 1139700219 CMS
Lilly USA, LLC $16.01 01/08/2024 Food and Beverage Undisputed 01/23/2026 1135468867 CMS
Lilly USA, LLC $16.91 04/22/2024 Food and Beverage Undisputed 01/23/2026 1135502232 CMS
Lilly USA, LLC $18.86 07/24/2024 Food and Beverage Undisputed 01/23/2026 1135502234 CMS
Mylan Specialty L.P. $20.89 01/10/2024 Food and Beverage Undisputed 01/23/2026 1147320105 CMS
Mylan Specialty L.P. $20.74 03/06/2024 Food and Beverage Undisputed 01/23/2026 1147338843 CMS
Mylan Specialty L.P. $30.20 05/13/2024 Food and Beverage Undisputed 01/23/2026 1147288248 CMS
Mylan Specialty L.P. $18.98 08/20/2024 Food and Beverage Undisputed 01/23/2026 1147296477 CMS
Mylan Specialty L.P. $19.11 10/31/2024 Food and Beverage Undisputed 01/23/2026 1147333543 CMS
Novo Nordisk Inc $14.51 01/08/2024 Food and Beverage Undisputed 01/23/2026 1097226584 CMS
Otsuka America Pharmaceutical, Inc. $23.14 05/02/2024 Food and Beverage Undisputed 01/23/2026 1118860017 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $31.21 06/12/2024 Food and Beverage Undisputed 01/23/2026 1153732465 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.05 07/03/2024 Food and Beverage Undisputed 01/23/2026 1153504337 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.